am 251 has been researched along with Absence Seizure Disorder in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Rijn, CM | 1 |
| Gaetani, S | 1 |
| Santolini, I | 1 |
| Badura, A | 1 |
| Gabova, A | 1 |
| Fu, J | 1 |
| Watanabe, M | 1 |
| Cuomo, V | 1 |
| van Luijtelaar, G | 1 |
| Nicoletti, F | 1 |
| Ngomba, RT | 1 |
1 other study available for am 251 and Absence Seizure Disorder
| Article | Year |
|---|---|
WAG/Rij rats show a reduced expression of CB₁ receptors in thalamic nuclei and respond to the CB₁ receptor agonist, R(+)WIN55,212-2, with a reduced incidence of spike-wave discharges.
Topics: Analysis of Variance; Animals; Benzoxazines; Disease Models, Animal; Electroencephalography; Epileps | 2010 |